Has Christopher Low, MD received payments from drug or device companies?

Yes. Drug and device makers reported $28,989 in general payments to Christopher Low, MD across 199 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Low, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Low, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Low, MD

Plastic and Reconstructive Surgery · The Villages, FLNPI 1659523066

Payments from drug & device makers

What this record shows

This record is dominated by gifts: $18,855 of the $28,989 with a category attached, or 65.0%. AbbVie accounts for 80.5% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $21,917 and has fallen 95.2% since, to $1,056 in 2025. Among plastic and reconstructive surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,989in general payments, 2019–2025

Across 199 payments — averaging $145.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$23K
Integra Lifesciences Corporation$2K
Musculoskeletal Transplant Foundation Inc.$705
Mentor Worldwide LLC$402
Baxter Healthcare$377
Axogen$296
plus $2K from 15 others

What the payments were for

Food & beverage$10,13435%
Gifts$18,85565%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	80	$23,338
Integra Lifesciences Corporation	60	$2,019
Musculoskeletal Transplant Foundation Inc.	6	$705
Mentor Worldwide LLC	13	$402
Baxter Healthcare	6	$377
Axogen	4	$296
Abiomed	2	$295
Innovation Technologies Inc	3	$280
Stryker(2 entities)	4	$278
Polynovo North America LLC	3	$224
Aroa Biosurgery Incorporated	1	$138
Sientra, Inc.	1	$126
Dilon Technologies, Inc.	3	$122
Acelrx Pharmaceuticals, Inc.	1	$104
TELA Bio, Inc.	4	$70
Kerecis Limited	1	$56
Acell, Inc.	2	$38
Galderma Laboratories, L.p.	2	$34
Motiva USA, LLC	1	$32
KCI USA, Inc.	1	$31
Organogenesis Inc.	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NATRELLE$19,898
NATRELLE SALINE-FILLED BREAST IMPLANTS$1,135
INTEGRA$805
ALLODERM$662
PRIMATRIX$503
INTEGRA DERMAL REGENERATION TEMPLATE$503
INTEGRA WOUND MATRIX (IWM)$451
Impella$295
INTEGRA MESHED BILAYER WOUND MATRIX$234
INTEGRA FLOWABLE WOUND MATRIX$234
BILAYER WOUND MATRIX (BWM)$216
AMNIOEXCEL$216
IDRT$216
FLOWABLE$216
MOLLI$206
Irrisept$170
AVANCE NERVE GRAFT$142
Novosorb BTM$140
SPY TECHNOLOGY$138
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$126

How this compares

$28,989 in reported general payments places this provider in the 90th percentile of 235 plastic and reconstructive surgery providers in Florida.

See all plastic and reconstructive surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$26,559

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	25	$248
Cephalexin	31	$171
Ondansetron Hcl	22	$153

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in The Villages

Alan DurkinVero Beach$548K
Edgar SosaVero Beach$504K
Vaishali DoolabhJacksonville$306K
Sai Ramakrishna Velamuri VenkataTampa$303K
Lee GibsteinBay Harbor Islands$216K
John MurrayJacksonville$188K
Arthur DesrosiersMiami$156K
Miguel MedinaMiami$80K
Roger KhouriCoconut Grove$80K
George KamelFort Lauderdale$54K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →